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SHORT COMMUNICATION
Bromodeoxyuridine-labelled apoptosis after treatment with
antimetabolites in two murine tumours and in small intestinal crypts
C.E. Sarraf, T.W. Ansaril, P. Conway', M. Notay', S. Hill2 & M.R. Alison'
'Department ofHistopathology, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London W12 ONN;
2Cancer Research Campaign Gray Laboratory, Mount Vernon Hospital, Northwood Middlesex, HA6 2RN, UK.
Summary Antimetabolites are S-phase specific anticancer drugs. Administration of bromodeoxyuridine
(BrdUrd) to tumour bearing mice was followed by treatment with cytosine arabinoside or hydroxyurea.
Anti-BrdUrd immunocytochemistry visualised susceptible tumour and intestinal crypt cells at electron micro-
scope level, showing unequivocally that cells that were in S-phase at the time of administration of the drugs
subsequently died by apoptosis.
Antimetabolites are commonly used anticancer drugs that
produce their cytotoxicity by targeting tumour cells in the
S-phase of the cell cycle. Ijiri and Potten (1987) found that a
wide range of chemotherapeutic agents caused cell death in
intestinal crypts and Anilkumar et al. (1992) determined by
electron microscope (EM) examination that this cell death in
the mouse, when treated with cytosine arabinoside (Ara-C)
or hydroxyurea (HU), was through apoptosis rather than
necrosis. In tumours, the precise mode of cell death after
chemotherapy is important, as apoptosis is considered as an
active, gene-directed process (Alison & Sarraf, 1992) which in
some circumstances it might be possible to selectively
enhance (Itoh et al., 1991). By injecting BrdUrd - a specific
precursor of DNA, followed by the antimetabolite, and
subsequently visualising the former by immunocytochemistry,
S-phase cells would be identified then tracked to their death.
Here, the nature of this cell death has been examined in two
transplantable murine tumours, a sarcoma, SaF, and a car-
cinoma, CaX, and in murine small intestinal crypts, in res-
ponse to treatment with Ara-C or HU.
Materials and methods
Tissues
All experiments were performed in male CBA mice bearing
either SaF or CaX, when the tumours were 1 cm in diameter.
Duodenal samples were obtained from the same animals.
Eight animals bearing SaF and eight bearing CaX were
treated with Ara-C and similar groups were treated with HU.
Each tumour-bearing group also contained two control
animals which received saline in the place of Ara-C or
HU.
Flash labelling with BrdUrd and subsequent cytotoxic drug
treatment
The method of Sarraf and Alison (1993) was used that
ultimately demonstrated S-phase cells that subsequently died
by apoptosis as determined by EM. BrdUrd was administer-
ed ip to all animals at a dose of 50 mg kg-', to identify
S-phase cells at the time of drug administration. One hour
later, Ara-C was given, ip, to four animals bearing SaF and
four bearing CaX at 1000 mg kg', 'high dose', and to the
other four of each at the 'low dose' of 100 mg kg-'. At each
of these dose levels, two animals were killed 2 h later, and
two were killed 4 h later. Also 1 h post BrdUrd, HU was
given, ip, to four animals bearing SaF and four animals
bearing CaX, at 1500 mg kg-' 'high dose' and to four bear-
ing SaF and four bearing CaX at 150 mg kg-' 'low dose'. At
each of these dose levels, once more, two animals were killed
2 h later, and two were killed 4 h later. Thus, all cells that
had been in the S-phase at the time of administration of
BrdUrd would be demonstrable by immunolabelling, and
their subsequent fate could be determined.
Tissuepreparation
Multiple samples of tumour and small intestine were taken
from all animals for routine preparation of EM blocks
(1 mm3), though without osmication. After embedding in
Araldite, first 1 ytm sections were cut and collected on PLL-
coated glass slides for light microscopy, followed by 100 nm
sections which were collected on nickel grids for electron
microscopy; post-embedding immunolabelling was carried
out in both cases. BrdUrd was demonstrated by immuno-
cytochemistry at light microscope level using a routine
peroxidase/antiperoxidase (PAP) technique after primary
incubation with rat anti-mouse monoclonal BrdUrd (Sera
Lab). Counter-staining was with (a) haematoxylin (b)
toluidine blue or (c) no counterstain on serial sections.
For demonstration of BrdUrd by immunocytochemistry at
EM level, incubation in rat anti-mouse monoclonal BrdUrd
(as above) was followed by incubation in gold-labelled secon-
dary goat anti-rat IgG then light routine counterstaining with
uranyl acetate and lead citrate. Results were observed on a
Philips CM 10 transmission electron microscope operated at
80 KV.
Cell counts
Mitotic indices (Im) and indices of apoptotic cell death (Iap)
were obtained at light microscope level from the 1 ILm resin
embedded sections. In tumours, areas to be scored were
selected randomly, although excluding areas of frank ischa-
emic necrosis. In the small intestine, only axially sectioned
crypts were selected for counting, in which the neck, middle
and base were all clearly visible; thus, excluding bias towards
any one zone of the crypt (Wright & Alison, 1984). In excess
of 2000 cells were counted per tissue sample (using more than
one block from a sample if necessary, to provide the suffic-
ient cell number). All mitotic and apoptotic figures respec-
tively were noted 'along the way' and indices were calculated
as percentages of mitotic and apoptotic bodies to the total
cell number in each case. In the case of apoptotic figures,
each fragment was scored as an individual, and no attempt
was made to estimate the original number of cells based on
the clustering of fragments.
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Results
As expected, both drugs rapidly reduced the mitotic index in
all tissues (Table I). Conversely, apoptotic indices universally
rose after treatment with each antimetabolite (Table II). The
greatest values were found in the duodenal crypts; these had
no apoptosis in controls in these specimens. At the dose
levels chosen, HU produced higher apoptotic indices than
Ara-C, in each tissue. An accurate BrdUrd-positive labelling
index could not be obtained because of overshadowing of
immunostain with counterstain, but by comparison ofcounter-
stained and non-counterstained/immunolabelled serial sections,
it was clear that the overwhelming majority of apoptotic cells
were peroxidase positive, peroxidase labelled non apoptotic
cells occurred. Necrotic tumour areas showed no BrdUrd
immunoreactivity.
In treated tissues at EM level, labelled dead and dying cells
were seen to be apoptotic, not necrotic and were easily
recognised by their characteristic appearance; condensed
chromatin caps of apoptotic nuclei were heavily labelled with
immunogold (Figures 1 and 2). Apoptosis was seen in all
tissue samples except control crypts in this case, and
organelles were generally less degraded after 2 h compared to
after 4 h.
In treated tumours, examples of unlabelled apoptotic cells
were sometimes seen because apoptosis occurs spontaneously
in tumours, while in control tumours the more infrequently
occurring apoptotic bodies were not BrdUrd labelled. Due to
the constraints of morphometry at EM level, indices of these
observations were not attempted in this investigation. In
treated crypts unlabelled apoptotic cells were not seen in our
samples, while in untreated crypts labelled cells were not
apoptotic.
Discussion
SaF and CaX are both transplantable experimental tumours
and reached a diameter of 1 cm by 4-6 weeks post-implant-
ation. Standardisation of tumour size for the investigation
justified comparison of interindividual cell kinetic parameters
(Sarraf & Bowen, 1986). Four hours post Ara-C and HU the
mitotic indices in SaF, CaX and duodenal crypts were dras-
tically reduced as might be expected after treatment with an
S-phase specific cytotoxic agent (Benton & Alison, 1984). We
observed no spontaneous apoptosis in our specimens of small
intestine in this investigation although it is known to occur at
a low level (Potten, 1977). Apoptotic indices in all these
tissues were elevated and by comparison with serial sections,
Table I Changes in average mitotic indices (Im)% after treatment
with Ara-C or HU
Crypts SaF CaX
Control values (n = 4) 2.3 1.2 1.2
+2h +4h +2h +44h +2/h +4h
Ara C (n = 8) (n = 8)
low dose 0.9 0.1 0.2 0.1 0.2 0.1
high dose 0.0 0.0 0.1 0.1 0.1 0.0
HU (n = 8) (n = 8)
low dose 0.4 0.0 0.7 0.0 0.3 0.0
high dose 0.1 0.0 0.2 0.0 0.1 0.0
Table II Changes in average apoptotic indices (Iap)% after
treatment with Ara-C or HU
Crypts SaF CaX
Control values (n = 4) 0.0 1.1 1.3
+2h +4h +2/h +4/h +2h +4h
Ara C (n = 8) (n = 8)
low dose 6.1 9.5 1.4 2.5 1.6 2.9
high dose 17.4 25.1 2.3 3.7 2.3 3.6
HU (n = 8) (n = 8)
low dose 26.1 39.0 11.6 16.2 4.2 7.5
high dose 44.0 52.2 16.4 20.2 7.6 13.1
Figure 1 An electron micrograph that shows two neighbouring
cells of the SaF tumour, after treatment with HU; their nuclei are
grossly distorted in shape, and each contains an apoptotic body
within a heterophagic vacuole. Degraded cytoplasmic organelles,
0, are present in the apoptotic bodies and the characteristic
chromatin caps, N, are labelled with immunogold identifying
BrdUrd uptake. (Bar = 1.0ftm).
Figure 2 An electron micrograph of the CaX tumour after
treatment with Ara-C and shows one vacuole-bound apoptotic
body. Cytoplasmic organelles are present, and the chromatin cap,
N, is labelled with anti-BrdUrd immunogold. (Bar=0.5 tm).
it was clear that the vast majority of apoptotic cells had been
in S-phase at the time of death. Apoptotic indices in crypts
after HU treatment in particular, were high. The normal
crypt contains around 30% S-phase cells (Wright & Alison,
1984), but apoptotic levels rose to above this figure in some
cases (Table II). The reason is that cells undergoing apoptosis
disrupt, and the scoring procedure used counted all frag-
ments observed rather than estimating the number of cells
from which the fragments were derived. Areas of necrosis
occur in SaF and CaX (Sarraf & Bowen, 1986), but these
were BrdUrd negative, showing that after treatment with
Ara-C or HU tumour necrosis was not enhanced by death of
S-phase cells.
At light microscope level, BrdUrd/peroxidase positive
apoptotic cells were present but had their typical brown label
masked by the density of the underlying condensed chroma-
tin even when counterstained lightly. In future, with a
method that gives better contrast, it would be interesting to680 C.E. SARRAF et al.
determine indices of unlabelled apoptoses and the proportion
of healthy cells that were BrdUrd positive after treatment.
These have not been quantified in this study as unequivocal
differentiation between peroxidase labelled apoptosis and
non-peroxidase labelled apoptosis was not possible.
Antimetabolite susceptible S-phase cells have been tracked
to cell death previously (Alison & Wright, 1981), using tri-
tiated thymidine followed by autoradiography, to label the
S-phase cohort. That investigation was at light microscope
level only: certain identification of apoptotic cells can only be
achieved by electron microscopy, particularly when there is a
high number of neighbouring dead and dying cells, which
might be mistaken for necrosis when observed at light micro-
scope level. EM autoradiography, however, is beset with
practical problems such as expense and length of time taken
for exposure of the tissue to photographic emulsion, so the
above technique offers a simple solution to this problem. In
situ end labelling is a recently developed technique for iden-
tifying apoptotic cells at light microscope level (Gavrieli et
al., 1992; Wijsman et al., 1993), but it would not discriminate
between those cells rendered apoptotic by the cytotoxics as
opposed to those apoptotic cells which occurred spontane-
ously.
It was central to this investigation to specifically identify
the cells targeted by the chemotherapeutic agents. Apoptotic
bodies were easily recognised at EM level and their member-
ship of the S-phase cohort at the time of Ara-C or HU
administration was confirmed by the immunogold label on
the condensed chromatin. One hour after injection of
BrdUrd the vast majority of S-phase cells would still be in
this phase and thus susceptible to the cytotoxic agents, while
4 h after administration of the antimetabolites was sufficient
time to monitor their fate. As expected, BrdUrd negative
apoptotic cells were sometimes seen in treated tumours due
to the low spontaneous level of apoptosis (Sarraf & Bowen,
1988), conversely, particularly at the lower dose levels of the
drugs, some cells (probably those that had been at the ex-
treme end of S-phase when BrdUrd was administered) were
able to survive in S-phase without being killed (Benton &
Alison, 1984), and thus be labelled without being apopto-
tic.
In conclusion, S-phase cells in the SaF and CaX tumours
and duodenal crypts died by apoptosis after exposure to
Ara-C or HU; higher doses of the drugs and longer exposure
resulting in higher levels of apoptosis but no necrosis. Brd-
Urd immunocytochemistry is the method of choice for iden-
tifying the drug-susceptible cells at electron microscope level
if their subsequent fate is to be accurately determined, partic-
ularly with respect to identifying apoptosis in contrast to
necrosis.
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